News & Events
New name comes on the heels of major growth period and reflects the company’s expanding digital health portfolio
Report shows 75% increase in new drug approvals compared to Q4 2020; Over 35% granted accelerated approval by the FDA
Articles & Press
As coronavirus disease 2019 (COVID-19) has transformed the world we live in, so too has it changed the paradigms of treatment for many cancers.
The following article is the fifth in a five-part series on The Top Five Ways for Health Plans to Manage Oncology Drug Costs While Improving Member Treatment Options.
Date: Wednesday, June 30, 2021
Time: 1:00 PM EST
Date: Thursday, June 3, 2021
Time: 2:00 PM EST